Drug Approval | June 27, 2024
Shilpa Medicare Bio Analytical unit gets "No Action Indicated" classification from USFDA
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Signs MoUs with Shri Krishna Ayush University and Dabur India
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
The facility was inspected from May 7 to May 17, 2024
This tie-up will have no impact on any other brands of the company
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Renews GMP certifications for India and Malaysia sites
Subscribe To Our Newsletter & Stay Updated
